|
|
|
Volumn 115, Issue 2, 2011, Pages 122-133
|
|
[Long-term efficacy and safety profile of pegaptanib sodium for age-related macular degeneration with choroidal neovascularization--evaluation of extended phase II clinical trial].
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
APTAMER;
PEGAPTANIB;
VASCULOTROPIN A;
AGED;
ARTICLE;
CLINICAL TRIAL;
DRUG ANTAGONISM;
FEMALE;
HUMAN;
MALE;
MULTICENTER STUDY;
PATHOPHYSIOLOGY;
PHASE 2 CLINICAL TRIAL;
RETINA MACULA DEGENERATION;
SUBRETINAL NEOVASCULARIZATION;
VISUAL ACUITY;
AGED;
AGED, 80 AND OVER;
APTAMERS, NUCLEOTIDE;
CHOROIDAL NEOVASCULARIZATION;
FEMALE;
HUMANS;
MACULAR DEGENERATION;
MALE;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VISUAL ACUITY;
|
|
EID: 79955644292
PISSN: 00290203
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|